Registration of share capital increase in IDEX Biometrics 24 May 2024

Reference is made to the notice on 15 May 2024 (corrected 20 May 2024) regarding a private placement of 33.3 million shares at NOK 1.65 per share, split in two tranches. The share capital of tranche 1 of the private placement has been registered and the shares will be delivered soonest. Following the issue, the company's share capital is NOK 46,210,015.20 divided into 308,066,768 shares, each with a nominal value of NOK 0.15. For further information contact:Marianne Bøe, Investor...
Oslo, (informazione.it - comunicati stampa - information technology)

Reference is made to the notice on 15 May 2024 (corrected 20 May 2024) regarding a private placement of 33.3 million shares at NOK 1.65 per share, split in two tranches.

The share capital of tranche 1 of the private placement has been registered and the shares will be delivered soonest.

Following the issue, the company's share capital is NOK 46,210,015.20 divided into 308,066,768 shares, each with a nominal value of NOK 0.15.

For further information contact:
Marianne Bøe, Investor Relations
E-mail: [email protected]
Tel: +47 918 00186

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market. 

For more information, visit www.idexbiometrics.com

About this notice
This notice was issued by Erling Svela, Vice president of finance, on 24 May 2024 at 10:30 CET on behalf of IDEX Biometrics ASA. The information shall be disclosed according to section 5‑8 of the Norwegian Securities Trading Act (STA) and released in accordance with section 5‑12 of the STA.


Per maggiori informazioni
Ufficio Stampa
 Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
Allegati
Slide ShowSlide Show
Non disponibili